Since its founding in 1806, Colgate-Palmolive has grown into a leading player in the household and personal care industry... Show more
Colgate-Palmolive shares have exhibited range-bound, defensive trading characteristics consistent with a large-cap consumer staples name. Over the past month, the stock drifted from the upper-$88 area to the mid-$84 level, a decline of approximately 5%, without any single, outsized catalyst driving the move. This modest pullback occurred against a backdrop of generally resilient demand for household and personal-care essentials, tempered by investor attention to valuation and the broader macroeconomic environment.
Consumer staples companies like Colgate-Palmolive are often viewed as defensive holdings, prized for their steady cash flows and relative resilience during periods of economic uncertainty. The recent price action suggests that while the stock has given back some ground, the underlying business fundamentals and market positioning remain intact.
Colgate-Palmolive is a leading global consumer products company operating across two primary segments: Oral, Personal and Home Care, and Pet Nutrition. Its portfolio includes iconic brands such as Colgate, Palmolive, Softsoap, Speed Stick, Tom's of Maine, and the Hill's Science Diet and Hill's Prescription Diet lines in pet care. The company sells its products in more than 200 countries and territories, giving it one of the most geographically diversified footprints in the industry.
The company's competitive strengths include a dominant position in global toothpaste sales, deep brand loyalty, extensive distribution networks, and a track record of innovation and premiumization. Its pet nutrition business, centered on the Hill's brand, has been a consistent growth driver, supported by rising pet ownership and a shift toward science-based nutrition. Colgate-Palmolive is also widely followed for its exceptional dividend history, having increased its payout annually for more than five decades, which appeals to income-oriented investors.
The most recent month has been marked by modest, orderly price movement rather than dramatic news flow. Colgate-Palmolive's business model continues to benefit from resilient consumer demand for everyday essentials, disciplined pricing, and productivity initiatives. The company's emphasis on premiumization across both its oral care and pet nutrition portfolios has supported stable operating performance, even as consumers remain value-conscious.
From a market perspective, the stock's slight pullback appears more consistent with broader sector dynamics and profit-taking in defensive names than with any fundamental deterioration. Investors continue to monitor how input costs, foreign currency translation, and promotional activity influence margins, as well as how the Hill's segment sustains its growth trajectory. Institutional positioning and sentiment toward consumer staples have remained measured, with the category serving as a ballast within diversified portfolios.
For traders and investors looking to complement their analysis with systematic, data-driven tools, Tickeron's Trending AI Robots page offers a curated view of its AI-powered trading bots. Tickeron hosts hundreds of AI trading bots that monitor thousands of tickers across a wide range of markets, but only the top-performing and most relevant bots are featured in this section. These bots vary in their strategies, timeframes, and performance metrics, allowing users to explore approaches that align with their own objectives and risk tolerance. Whether you are focused on short-term momentum or longer-term trends, the Trending AI Robots page provides a convenient starting point for discovering automated strategies currently drawing attention.
Looking ahead, several factors are likely to shape Colgate-Palmolive's performance through 2026. Organic sales growth, driven by a combination of pricing and volume trends, will remain a key metric for investors, particularly as inflationary pressures on raw materials and packaging evolve. The performance of the Hill's Pet Nutrition segment will also be closely watched, given its role as a growth engine within the portfolio.
Currency movements represent a persistent variable for a company with such extensive international exposure, as do competitive dynamics across emerging and developed markets. Investors will also monitor gross and operating margins, advertising and promotional spending, and the company's ability to sustain its long-running dividend increases. Macroeconomic conditions, including consumer spending patterns and interest-rate expectations, may influence how defensive staples names like Colgate-Palmolive are valued relative to other sectors. While the company's fundamentals remain solid, the pace and durability of organic growth will be central to the stock's trajectory in the year ahead.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
CL saw its Momentum Indicator move above the 0 level on October 06, 2026. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 68 similar instances where the indicator turned positive. In 33 of the 68 cases, the stock moved higher in the following days. The odds of a move higher are at 49%.
The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where CL's RSI Indicator exited the oversold zone, 13 of 28 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 46%.
The Moving Average Convergence Divergence (MACD) for CL just turned positive on October 06, 2026. Looking at past instances where CL's MACD turned positive, the stock continued to rise in 21 of 44 cases over the following month. The odds of a continued upward trend are 48%.
CL moved above its 50-day moving average on October 12, 2026 date and that indicates a change from a downward trend to an upward trend.
Following a +2.13% 3-day Advance, the price is estimated to grow further. Considering data from situations where CL advanced for three days, in 143 of 314 cases, the price rose further within the following month. The odds of a continued upward trend are 46%.
The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 3 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where CL declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 46%.
CL broke above its upper Bollinger Band on October 12, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for CL entered a downward trend on October 12, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron SMR rating for this company is 8 (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is 12 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 47 (best 1 - 100 worst), indicating steady price growth. CL’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 58 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 90, placing this stock slightly better than average.
The Tickeron Valuation Rating of 93 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: CL's P/B Ratio (294.118) is very high in comparison to the industry average of (18.044). P/E Ratio (34.063) is within average values for comparable stocks, (43.673). Projected Growth (PEG Ratio) (1.577) is also within normal values, averaging (1.518). Dividend Yield (0.024) settles around the average of (0.024) among similar stocks. P/S Ratio (3.331) is also within normal values, averaging (1.931).
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a maker of oral, personal, and household products
Industry HouseholdPersonalCare